To report the possible role of S.B 8.4% in the treatment of COVID-19pneumonia.
Drug: Sodium Bicarbonate
Inhalation of Sodium Bicarbonate 8.4% via nebulizer
Inclusion Criteria:
- Age >18 years.
- Fever ≥ 38º C with upper respiratory tract manifestations, generalized bone ache with
or without gastrointestinal symptoms as diarrhea.
- Chest CT with signs suggestive of COVID-19.
- Mild and moderate cases of COVID-19 pneumonia with respiratory and hemodynamic
stability. - High C reactive protein (CRP).- With or without history of contact with
index case who is isolated in a governmental hospital assigned for treatment of
patients proved to have RT-PCR positive test for COVID-19
- With or without abnormalities in the total or differential white cell count.
- Welling to sign a fully informed consent.
Exclusion Criteria:
- Severe and critical illness with respiratory failure and/ or hemodynamic instability.
- CT with pleural effusion with or without lung cavitation.
- Other organ failure.
Gomhoria Street
Mansoura, Outside U.S./Canada, Egypt
Mohammed K Elbadrawy, PhD, Principal Investigator
Chest department Mansoura University Hospital